This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
The the headquarters of this VC is in Stockholm. This investor is located in Europe, Sweden.
Among the most popular investment industries for the fund are Pharmaceutical, Hospital. However, the fund’s focus is not limited to this, since there are 8 more areas of investment. Light Sciences Oncology, AdvanDx, OxThera are among the most popular portfolio start-ups of the fund. The country of its establishment and the country of its most frequent investments doesn't coincide - Denmark. However, start-ups from 3 other countries can be found in the fund's portfolio. The fund has an exact preference in the amount of founders of companies in its portfolio. Moreover, a start-up needs to be 6-10 years old to get investment from this fund.
The fund usually invests in rounds together with 3-4 others. Aside from SLS Venture, start-ups are often funded by LD Pensions, Novo Holdings, Essex Woodlands Healthcare Partners. Other VCs who often invest in the same rounds are LD Pensions, Novo Holdings, Essex Woodlands Healthcare Partners, the total number of co-investors is 1. The investors in the following rounds are usually LD Pensions, Industrifonden, Sunstone Life Science Ventures, and 4 VCs in total.
In real terms, this VC performs 1 percentage points more exits than other funds. The fund typically enters into less than 2 deals annually. In comparison with other funds, SLS Venture makes 8 percentage points less than the average number of lead investments. The most common rounds for this fund are in the range of 10 - 50 millions dollars. We recorded the biggest number of exits for this fund in 2019. This fund was the most active in 2005.
Mail Rule [rules by which you can get an email of an interesting for you fund employee, knowing only the name and surname of this employee]
Domain name: slspro.net; User name format in descending order of probability: first
Group Appearance [how often fund is operating separately from groups with shared interest]
100.0% of cases
Follow-on Index [how often fund is ready to support its portfolio startup at next rounds]
35.7% of cases
By posting comments on our website you confirm and acknowledge that:
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.